This programme provides a comprehensive overview of obesity management medications, with a particular focus on GLP-1 receptor agonists, their use in the UK, and associated nutritional considerations. It brings together multidisciplinary perspectives, including dietetic, psychological, and patient viewpoints, to explore both the clinical application and lived experience of these treatments. The session concludes with a panel discussion examining the role of nutrition professionals within this evolving area of practice.
This event is free for Nutrition Society members. Please log into your account before registering to ensure you are not charged.
Registration will close on 26 April 2026 at midnight.
Welcome & Introduction
Hilda Mulrooney and Penny Hunking
GLP-1 Receptor Agonists and Obesity Management Medications: use, evidence, safety, and future directions in the UK
Dr Laurence Dobbie
NIHR Academic Clinical Fellow in General Practice, King’s College London, UK
Clinical Fellow in Obesity Medicine, Guy’s and St Thomas’ NHS Foundation Trust
Nutritional aspects in obesity management medication. Considerations before, during and after GLP-1 obesity treatment: the role of the registered dietitian
Dr Daniela Ojeda Mercado
Koelliker Hospital, Turin, Italy
Psychological considerations of obesity management medications
Dr Clarissa Dakin
University of Leeds, UK
Using obesity management medications – the patient perspective
Sarah Le Brocq
Founder & Director, All About Obesity, UK
Panel discussion: Where does the nutritionist fit in?
This is an online event only.
Registration will close on 26 April 2026 at midnight. We are sorry but registrations after this time cannot be accepted.
Member - To benefit from the membership rate, please log in to your membership area before completing the registration.
Non - Member